Fibrin for Chronic Multi-level Discogenic Low Back Pain
Status unconfirmed · Phase 2/Phase 3
Conditions studied: Low Back Pain, Disc Disease, Disc Degeneration, Radiculopathy, Annular Disc Tear
In brief
Intra-annular injections of non-autologous fibrin for moderate to severe chronic low back pain (LBP).
Key facts
- Study ID
- NCT04621799
- Run by
- Pauza, Kevin, MD
- People needed
- 400
- Starts
- 2018-06-11
- Expected to finish
- 2021-06-30
- Last updated by the study team
- 2020-11-09
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Recipient of Intra-annular fibrin injection for annular defects identified radographically and by annulogram
You may not qualify if…
- Scoliosis greater than 20 degrees
- Spondylolysis
- Spondylolisthesis greater than Grade 1
- Disc extrusion
- Disc herniations or bulges > 4mm causing severe stenosis
- Prior lumbar surgery or intradiscal procedure (i.e. intradiscal electrothermal therapy, nucleoplasty)
- Cauda equina syndrome
- Active malignancy or tumor as source of symptoms
- Evidence of prior lumbar vertebral body fracture or trauma
- Foraminal stenosis at the affected levels resulting in severe thecal sac compression
- Dynamic instability on lumbar flexion/extension radiographs
- Positive response to diagnostic medial branch block or facet joint injection or sacroiliac joint injection
- Known bleeding disorder
- Known or suspected hypersensitivity or allergy to drugs or components of the fibrin sealant, including aprotinin, used in the procedure
- Presence of ferromagnetic implants that would interfere with MRI evaluations
- Active or pending workers' compensation claims or other litigation related to the condition.
- Pregnant or plans to become pregnant over the course of study participation (2 years)
Where it is running
- Interventional Spine Specialist — Tyler, Texas, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.